Arcutis director granted RSUs and options
Arcutis Biotherapeutics director Halley E. Gilbert reported equity awards rather than open-market trades.
Rhea-AI Filing Summary
Arcutis Biotherapeutics director Halley E. Gilbert reported equity awards rather than open-market trades. On June 5, 2026, Gilbert received 5,778 Restricted Stock Units (RSUs) in connection with service as a non-employee director. Each RSU will convert into one share of common stock when it vests.
The RSUs vest on the earlier of the first anniversary of the grant date, June 5, 2026, or immediately before the next annual meeting of stockholders, subject to continued service. On the same date, Gilbert was also granted a stock option for 16,667 shares of common stock at an exercise price of $21.23 per share, vesting on the same schedule. Following the RSU grant, Gilbert directly owns 27,901 shares of common stock.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 22,445 shares
Grant/Award
2 txns
Insider
Gilbert Halley E
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Stock Option (right to buy) | 16,667 | $0.00 | $0.00 |
| Grant/Award | Common Stock | 5,778 | $0.00 | $0.00 |
Holdings After Transaction:
Stock Option (right to buy) — 16,667 contracts (Direct);
Common Stock — 27,901 shares (Direct)
Footnotes (2)
- F1. Represents Restricted Stock Units ("RSUs") granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders. The Reporting Person is entitled to receive one (1) share of common stock for each one (1) RSU upon the vesting thereof, which shall occur on the earlier of the first anniversary of the grant date, June 5, 2026, or immediately before the next annual meeting of stockholders, subject to the continued service through the vesting date.
- F2. The underlying shares subject to the option vest and become exercisable as to 100% on the earlier of the first anniversary of the grant date, June 5, 2026, or immediately before the next annual meeting of stockholders, subject to the continued service through the vesting date.
Key Figures
RSU grant: 5,778 RSUs
Stock option grant: 16,667 options
Option exercise price: $21.23 per share
+3 more
6 metrics
RSU grant
5,778 RSUs
Granted June 5, 2026 for non-employee director service
Stock option grant
16,667 options
Granted June 5, 2026 on common stock
Option exercise price
$21.23 per share
Conversion/exercise price of stock option grant
Common shares held
27,901 shares
Total common stock directly owned after RSU grant
RSU vesting date
June 5, 2026
Vest on earlier of this date or before next annual meeting
Option expiration
June 5, 2036
Expiration date of stock option grant
Key Terms
Restricted Stock Units ("RSUs"), non-employee director, annual meeting of stockholders, vesting, +1 more
5 terms
Restricted Stock Units ("RSUs") financial
"Represents Restricted Stock Units ("RSUs") granted in connection with the Reporting Person's service as a non-employee director"
Restricted stock units (RSUs) are a company promise to give an employee shares of stock (or cash equivalent) in the future, but only after certain conditions—usually staying with the company for a set time or hitting performance goals—are met. Investors watch RSUs because when they vest they increase the number of shares outstanding and can lead insiders to sell shares, affecting share price, company dilution and the true cost of employee pay.
non-employee director financial
"RSUs granted in connection with the Reporting Person's service as a non-employee director as of the Company's 2026 annual meeting of stockholders"
annual meeting of stockholders financial
"as of the Company's 2026 annual meeting of stockholders"
vesting financial
"upon the vesting thereof, which shall occur on the earlier of the first anniversary of the grant date"
Vesting is the process by which you earn full ownership of something, like company stock or a retirement benefit, over time. It’s like earning the right to keep a gift piece by piece the longer you stay with a company, making sure employees stay committed before they receive all the benefits.
Stock Option (right to buy) financial
"Stock Option (right to buy)"
FAQ
What insider transactions did Halley E. Gilbert report for Arcutis Biotherapeutics (ARQT)?
Halley E. Gilbert reported receiving equity awards, not open-market trades. He was granted 5,778 RSUs and a stock option for 16,667 shares, both tied to his service as a non-employee director and vesting over time.
What are the terms of the RSU grant to Halley E. Gilbert at Arcutis (ARQT)?
Gilbert received 5,778 RSUs as a non-employee director. Each RSU entitles him to one share of common stock upon vesting, which occurs on the earlier of June 5, 2026 or immediately before the next annual stockholder meeting, assuming continued service.
What are the key details of Halley E. Gilbert’s stock option grant from Arcutis (ARQT)?
Gilbert was granted a stock option for 16,667 shares of Arcutis common stock at an exercise price of $21.23 per share. The option vests 100% on the earlier of June 5, 2026 or immediately before the next annual meeting, subject to continued service.
Are Halley E. Gilbert’s reported Arcutis (ARQT) transactions considered purchases or compensation grants?
The reported transactions are compensation grants, not market purchases. Both the 5,778 RSUs and the 16,667-share stock option were awarded in connection with Gilbert’s role as a non-employee director, with vesting tied to his continued board service.
AI-generated analysis. How Rhea-AI works. Not financial advice.
